"Phosphorylcholine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
| Descriptor ID |
D010767
|
| MeSH Number(s) |
D02.092.877.883.333.700 D02.675.276.232.700
|
| Concept/Terms |
Phosphorylcholine- Phosphorylcholine
- Choline Phosphate
- Phosphate, Choline
- Phosphorylcholine Chloride
- Chloride, Phosphorylcholine
- Phosphocholine
- Choline Chloride Dihydrogen Phosphate
- Choline Phosphate Chloride
- Chloride, Choline Phosphate
- Phosphate Chloride, Choline
|
Below are MeSH descriptors whose meaning is more general than "Phosphorylcholine".
Below are MeSH descriptors whose meaning is more specific than "Phosphorylcholine".
This graph shows the total number of publications written about "Phosphorylcholine" by people in this website by year, and whether "Phosphorylcholine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 1 | 0 | 1 |
| 1998 | 2 | 0 | 2 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 1 | 1 | 2 |
| 2017 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
| 2024 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Phosphorylcholine" by people in Profiles.
-
Leishmania donovani mitogen-activated protein kinases as a host-parasite interaction interface. Cytokine. 2024 07; 179:156627.
-
Myotubularin-related protein 6 is an ion channel-associated pro-leishmanial phosphatase. Int Immunopharmacol. 2024 Mar 10; 129:111644.
-
Corneal Manifestations of Miltefosine Toxicity in Acanthamoeba Keratitis. Ophthalmology. 2021 09; 128(9):1273.
-
The drug resistance mechanisms in Leishmania donovani are independent of immunosuppression. Cytokine. 2021 09; 145:155300.
-
A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors. PLoS One. 2017; 12(6):e0178593.
-
Distinct Lipidomic Landscapes Associated with Clinical Stages of Urothelial Cancer of the Bladder. Eur Urol Focus. 2018 12; 4(6):907-915.
-
A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors. Pediatr Blood Cancer. 2017 Jul; 64(7).
-
Novel agents for multiple myeloma to overcome resistance in phase III clinical trials. Semin Oncol. 2013 Oct; 40(5):634-51.
-
Linker for activation of T-cell family member2 (LAT2) a lipid raft adaptor protein for AKT signaling, is an early mediator of alkylphospholipid anti-leukemic activity. Mol Cell Proteomics. 2012 Dec; 11(12):1898-912.
-
Perifosine , an oral, anti-cancer agent and inhibitor of the Akt pathway: mechanistic actions, pharmacodynamics, pharmacokinetics, and clinical activity. Expert Opin Drug Metab Toxicol. 2012 May; 8(5):623-33.